Trying to get medicine approved by the US Food and Drug Administration often feels like buying an expensive lottery ticket, with the uncertain prospect of a reward years away. It takes about a decade and more than $1 billion on average to take a drug through all the stages of clinical trials, and about 90% never get that far.
Part of the problem is the way researchers discover treatments. Until recently, scientists would come up with a hypothesis and run numerous tests to find a chemical capable of shutting down, say, a disease-causing protein. Then they’d run additional tests to ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.